Understanding Herpes zoster ophthalmicus (ocular shingles)
Herpes zoster ophthalmicus, or HZO, involves the forehead and eye region supplied by the ophthalmic division of the trigeminal nerve. The virus can reactivate after earlier chickenpox. Skin involvement and involvement inside the eye are different findings: neither the rash size nor a photograph of it measures visual ability. [8] [12]
Corneal inflammation, inflammation inside the eye and raised eye pressure can occur in different combinations. Some problems recur after the initial skin episode. A clinical examination and follow-up plan address the particular structures involved; a clearer-looking scene does not establish that inflammation or pressure has settled. [1] [8]
One condition. Different experiences.
Explore different selected symptom features, then read how they may vary. These examples are not stages or a clinical test.
Original VisualSim schematic illustrations, informed by the cited clinical descriptions. These are not study figures, patient recordings or validated severity levels.
Blur and difficulty with detail
Inflammation or later scarring can interfere with a clear corneal image. The page offers uniform blur as one communication example, not a reconstruction of an individual cornea, an acuity score or evidence of active infection. [1] [8]
Light sensitivity and pain
Light can become uncomfortable during eye inflammation. Skin or nerve pain may persist after the rash heals, while damage to corneal nerves can reduce sensation. Pain level therefore cannot reliably measure eye damage. A screen effect cannot reproduce discomfort or numbness. [1] [8]
Symptoms can change over time
Recurrent redness, light sensitivity or blurred vision should prompt renewed eye advice rather than being dismissed as the old rash. New floaters or a field change need urgent assessment for posterior-eye problems and other causes. [1] [6]
Nerve distribution, eye findings and follow-up
Original educational process diagram. It is not a nerve scan, patient recording or prediction of an individual course. [1] [8] [9]
Original VisualSim teaching diagram · © VisualSim. Clinical basis in linked sources; not a published study figure. Image provenance.- Reactivation
Varicella-zoster can reactivate in sensory nerves supplying the forehead and eye region.
- Different tissues
The rash, corneal findings, internal inflammation and eye pressure require separate assessment.
- Ongoing review
Skin recovery, recurrence prevention, pain care and useful vision can need different follow-up plans.
What is happening—and what remains uncertain
Varicella-zoster can remain latent in sensory nerves and later reactivate. HZO refers to the ophthalmic nerve distribution; it does not mean every person has identical corneal infection or damage at the back of the eye. Age and immune suppression affect risk, but younger people can also develop it. [3] [8]
Viral activity and the body’s inflammatory response can affect different ocular tissues. Rare neuro-ophthalmic complications include optic-nerve or eye-movement involvement and may require investigation beyond routine surface care. New neurological symptoms cannot be assessed by matching a visual example. [8] [9]
What can look similar?
Herpes simplex eye disease
HSV is a different virus. Its corneal patterns and treatment evidence must not be transferred automatically to ocular shingles. A prior cold sore, a red-eye photograph or similar blur does not establish which virus is responsible. [8]
Microbial keratitis and other red eyes
Bacterial, fungal and other corneal infections can also reduce clarity and cause discomfort. Examination distinguishes these from zoster-related disease; do not self-treat an undiagnosed painful eye using leftover steroid drops. [8] [12]
Retinitis and retinal emergencies
Retinal involvement is less common than anterior-eye disease but can threaten vision. Floaters or field loss also occur with retinal breaks and other conditions. The symptom image cannot identify viral retinitis or exclude detachment. [8] [9]
Persistent nerve pain versus active ocular inflammation
Postherpetic neuralgia describes ongoing pain after shingles. It can coexist with, or occur separately from, active eye disease. Pain care and ophthalmic monitoring answer different questions; recurrent visual symptoms still need eye advice. [1] [10]
Similar-looking symptoms can have different causes. A matching picture cannot establish a diagnosis.
What an assessment may involve
- Tell the clinician about onset and contextRecord when pain, rash and visual symptoms began, which side is affected and any immune-suppressing medicines or health conditions. Bring a medication list and describe changes since the last examination. A missing rash does not justify ignoring concerning eye or neurological symptoms. [2] [3] [9]
- Examine the eye, rather than judging the rashClinicians may check visual acuity, the cornea and ocular surface, internal inflammation and eye pressure. Symptoms or findings can also justify dilated retinal examination and other targeted tests. The aim is to identify affected structures and complications, not simply confirm a familiar skin pattern. [1] [8] [12]
- Agree on follow-up and a return routeAsk which signs should trigger a same-day call and who to contact outside clinic hours. Repeat assessment can matter during recurrence or treatment changes even after the skin heals. Follow-up timing depends on the actual eye findings and treatment. [1] [6]
What may help—and what is still being studied
Prompt antiviral assessment
Clinicians use antiviral medicines to control the acute infection, with early treatment particularly important. The often-cited first 72 hours is a reason to seek care promptly, not a reason to stay home if that interval has passed. Drug choice, kidney function, immune status and severity affect the plan. [3] [12]
Treat inflammation and pressure under supervision
Steroid eye drops may be appropriate for selected inflammation, with antiviral management and pressure monitoring directed by the eye team. Treatment can need a careful taper. Do not independently restart, stop abruptly or share drops from a previous episode; different corneal findings require different decisions. [1] [8]
Discuss recurrence prevention separately from acute treatment
The ZEDS trial supports discussing a year of suppressive valacyclovir in selected immunocompetent adults with recent HZO keratitis or iritis. Its 12-month primary result was not statistically significant; later secondary outcomes favored treatment. This is not a universal prescription for all shingles, children, pregnancy or immune suppression. [5]
Plan vaccination using current local guidance
Vaccination helps prevent shingles and its complications; it does not treat an acute episode. Current US CDC recommendations include adults aged 50 or older and adults aged 19 or older with relevant immune compromise. Eligibility differs internationally. With prior HZO, discuss disease control, timing and follow-up with the eye team; an observational recurrence signal does not by itself overturn vaccine recommendations. [4] [7]
Address pain and useful vision
Persistent pain deserves its own management plan. If residual visual difficulty affects reading, work or daily living, ask about rehabilitation alongside medical treatment. Treating inflammation, relieving pain and adapting a task are related but distinct goals. [10] [11]
What this can mean for daily life
Keep a simple episode and medication record
Write down symptom onset, changes and the actual prescribed schedule so you can describe a recurrence clearly. Ask the clinic to provide accessible instructions if small print or light sensitivity makes medication management difficult. [1] [11]
Reduce avoidable irritation
Follow your clinician’s surface-care advice, avoid rubbing the eye and pause contact-lens wear during active symptoms until the eye team says it is appropriate to restart. Adjust comfortable lighting without treating light avoidance as a substitute for assessment. [1]
Protect vulnerable contacts during an active rash
A person exposed to the blister fluid can develop chickenpox if susceptible; they do not directly catch shingles from you. Follow local advice about keeping lesions covered where possible, hand hygiene and contact with susceptible pregnant people, newborns and people with weakened immunity until lesions are dry and crusted. [2]
Make reading and work more manageable
Consider larger text, audio and breaks, and request task-specific workplace or study adjustments when needed. Do not drive if sight or symptoms make it unsafe; ask about local visual standards and when reassessment is needed. The simulator cannot establish fitness to drive. [11]
Find support with the right scope
The UK Shingles Support Society offers shingles and persistent-pain information and connection routes. Broader vision-rehabilitation services may help with lasting functional difficulty. These support services do not replace urgent ophthalmic care or establish eligibility in every country. [10] [11]
Bring a clearer description to your appointment
Choose the questions you want to discuss. These choices stay in this page’s memory.
Research, with the context left in
Selected studies and guidance, with their populations and limitations. These are curated educational summaries, not a complete systematic review or a formal evidence rating.
ZEDS: suppressive antiviral treatment for selected HZO eye disease
At 12 months, the primary endpoint occurred in 28% assigned valacyclovir and 33% assigned placebo (HR 0.77, adjusted 95% CI 0.56–1.05; P=.09). At 18 months, the secondary endpoint favored treatment (HR 0.73, 95% CI 0.55–0.97). Multiple-episode outcomes also favored treatment. [5]
Limits and applicability: The primary endpoint was not statistically significant. Selected eligibility and secondary outcomes limit generalization; this is not evidence of virus eradication or guaranteed visual recovery.
Long-term recurrence in an eye-center cohort
At least one recurrence was recorded in 200 people (23%). Recurrence was associated with presenting immune suppression, pressure and inflammatory findings; more recurrences accompanied greater observed visual loss. [6]
Limits and applicability: Referral population, retrospective records and treatment selection prevent causal conclusions or an individual recurrence forecast. The association does not prove that stopping a prescribed steroid causes recurrence or justify indefinite self-treatment.
Vaccination and short-term recurrence after previous HZO
Within the 56-day primary window, recombinant zoster vaccination was associated with a higher recurrence hazard (adjusted HR 1.64, 95% CI 1.01–2.67). The authors support considering post-vaccination eye monitoring in people with previous HZO. [7] [4]
Limits and applicability: Claims-based outcome definitions and residual confounding limit causal interpretation. This studied recurrence after prior HZO, not the vaccine’s overall benefit in preventing first shingles episodes; it is not a reason to replace current vaccination guidance.
Questions researchers still need to answer
- Which recurrence patterns and immune or kidney-function groups benefit most from suppressive treatment beyond the selected ZEDS population?
- How should vaccination timing and monitoring be individualized after HZO while preserving the vaccine’s preventive benefits?
- Which combined pain, corneal-sensation and rehabilitation outcomes best reflect day-to-day function, beyond counting inflammatory episodes?
Trusted places to go next
Selected clinical references, research, practical support and ways to connect. Official pages checked 24 October 2026; each entry explains its scope and region.
Moorfields: ocular shingles
Condition-specific patient explanation of eye involvement, treatment and recurrence; use local urgent-care routes outside its service area.
Shingles Support Society
A subgroup of registered charity Herpes Viruses Association offering shingles and postherpetic-pain information, volunteer support and a paid information-pack connection route. It is not an ophthalmic emergency service.
Connections listed by the organization.
CDC: shingles vaccine recommendations
Current US preventive-vaccination recommendations, including prior shingles and immune-compromised populations. Discuss personal timing with the treating clinicians.
NEI: vision rehabilitation
Broader help with assistive technology, daily activities, employment and emotional support when lasting visual difficulty affects function. Not a zoster-specific treatment program.
Questions you may still have
Is ocular shingles the same as herpes simplex keratitis?
No. Shingles is varicella-zoster reactivation; HSV eye disease has a different virus and its own evidence. Similar redness or blur cannot distinguish them at home. [8]
If my rash has healed, can eye problems still recur?
Yes. Recurrent corneal or internal inflammation can occur after the skin episode. New eye symptoms need advice; skin healing alone does not establish eye health. [1] [6]
Does the simulator show pain or tell me whether the eye is safe?
No. It illustrates selected blur only. It cannot reproduce pain, measure corneal sensation or check inflammation, eye pressure, retina or the optic nerve. [1] [8]
Should I take a year of antivirals or avoid vaccination?
These require individual discussions. ZEDS enrolled a selected adult group and had a nonsignificant primary result with favorable secondary outcomes. Vaccination remains recommended for eligible people; prior HZO can warrant attention to timing and monitoring. [5] [7] [4]
Can I pass shingles to someone else?
You do not directly give another person shingles, but susceptible contacts can catch chickenpox from the active blistering rash. Follow local infection-control advice and protect vulnerable contacts. [2]
Sources, image credits and review status
Compiled by VisualSim from clinical references and published research. Sources checked 24 October 2026. Independent clinical review has not been recorded; no named clinical reviewer or clinical validation is claimed. Research evidence and its limitations are linked below.
- Moorfields — Ocular shingles (2023; review due 2024; institution).
Patient text read directly. Older vaccine-age section not used; current CDC/local guidance kept separate.
Checked 2026-10-24 · Public page checked - NHS — Shingles (2023; current page checked 2026; institution).
Urgency, susceptible-contact advice and symptoms read; local service details are not worldwide instructions.
Checked 2026-10-24 · Public page checked - CDC — Clinical overview of shingles (2024; current page checked 2026; institution).
Current primary public-health treatment and risk statements read; no individual dosing supplied.
Checked 2026-10-24 · Public page checked - CDC — Shingles vaccine recommendations (2024; current page checked 2026; guideline).
US age and immune-compromise recommendations checked; prevention distinguished from acute treatment.
Checked 2026-10-24 · Public page checked - Cohen et al. — Low-dose valacyclovir in HZO: ZEDS randomized clinical trial (2025; trial).
Original indexed abstract read for 527 randomized participants, eligibility and primary/secondary endpoint hierarchy. Direct PMC reader challenged; no full-text access claim.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - Scott et al. — HZO recurrence, risk factors and long-term clinical outcomes (2024; observational).
Original abstract read: 869 people, median 6.3 years of follow-up and 200 people with at least one recurrence. Treatment associations are not interpreted causally.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - Walia et al. — HZO recurrence after recombinant zoster vaccination (2024; observational).
Original methods/results/limitations read; 16,408 matched prior-HZO cohort and 56-day claims-derived outcome, not vaccine prevention trial.
Checked 2026-10-24 · Full text checked - Litt et al. — HZO presentation, complications, treatment and prevention (2024; review).
Original indexed abstract read for anatomical scope and complications. Direct PMC request challenged; GSK affiliation/funding context means this review is not the sole vaccine basis.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - Tao, Soor and Micieli — Herpes zoster in neuro-ophthalmology (2024; review).
Original indexed abstract read for rarer neuro-ophthalmic involvement; no frequency or treatment effect inferred.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - Shingles Support Society — About and support scope (2026; institution).
Official charity page read, including parent charity 291657, volunteer connection pack and support scope. Contact page separately checked; no private group joined.
Checked 2026-10-24 · Public page checked - National Eye Institute — Vision rehabilitation (2026; institution).
Current March 2026 page read for daily-living, technology and support options; broader visual-impairment resource rather than HZO treatment.
Checked 2026-10-24 · Public page checked - College of Optometrists — HZO clinical management guideline public summary (2025; guideline).
Public summary and 14 August 2025 revision metadata read. Member-only detailed recommendations not accessed or claimed.
Checked 2026-10-24 · Public page checked
The simulator helps people communicate an experience. It cannot diagnose a condition, measure a visual field, or establish that someone is safe to drive.